Electromed Inc (ELMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Electromed Inc (ELMD) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.03 Million) by net assets ($45.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Electromed Inc (ELMD) market capitalisation for the company's overall valuation and market capitalisation.
Electromed Inc - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Electromed Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Electromed Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Electromed Inc ranked by their cash flow conversion efficiency. Explore how high is Electromed Inc's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Canaan Inc
NASDAQ:CAN
|
-0.742x |
|
Quarterhill Inc
TO:QTRH
|
0.073x |
|
Teamlease Services Limited
NSE:TEAMLEASE
|
0.042x |
|
Hocheng Corp
TW:1810
|
-0.001x |
|
Kina Securities Ltd
AU:KSL
|
0.015x |
|
Pulmuone Holdi
KO:017810
|
0.016x |
|
cBrain A/S
CO:CBRAIN
|
0.133x |
|
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL
|
-0.143x |
Annual Cash Flow Conversion Efficiency for Electromed Inc (2008–2025)
The table below shows the annual cash flow conversion efficiency of Electromed Inc from 2008 to 2025. View ELMD stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $43.21 Million | $11.39 Million | 0.264x | +29.54% |
| 2024-06-30 | $44.55 Million | $9.07 Million | 0.204x | +483.04% |
| 2023-06-30 | $37.67 Million | $1.31 Million | 0.035x | +273.91% |
| 2022-06-30 | $34.17 Million | $-686.00K | -0.020x | -121.15% |
| 2021-06-30 | $32.42 Million | $3.08 Million | 0.095x | -31.57% |
| 2020-06-30 | $30.25 Million | $4.20 Million | 0.139x | +37.83% |
| 2019-06-30 | $25.73 Million | $2.59 Million | 0.101x | -9.77% |
| 2018-06-30 | $21.90 Million | $2.44 Million | 0.112x | +78.56% |
| 2017-06-30 | $19.07 Million | $1.19 Million | 0.062x | -52.84% |
| 2016-06-30 | $16.36 Million | $2.17 Million | 0.132x | -33.69% |
| 2015-06-30 | $13.92 Million | $2.78 Million | 0.200x | +23.19% |
| 2014-06-30 | $12.72 Million | $2.06 Million | 0.162x | +20.34% |
| 2013-06-30 | $13.93 Million | $1.88 Million | 0.135x | +273.42% |
| 2012-06-30 | $15.08 Million | $-1.17 Million | -0.078x | +19.25% |
| 2011-06-30 | $14.71 Million | $-1.42 Million | -0.096x | -218.12% |
| 2010-06-30 | $7.46 Million | $607.94K | 0.081x | +142.63% |
| 2009-06-30 | $6.06 Million | $-1.16 Million | -0.191x | -417.55% |
| 2008-06-30 | $4.04 Million | $243.16K | 0.060x | -- |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more